Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1951 2
1952 1
1954 1
1955 1
1957 1
1959 2
1963 3
1964 1
1965 3
1966 3
1968 4
1969 1
1970 9
1971 7
1972 8
1973 5
1974 13
1975 10
1976 12
1977 16
1978 26
1979 21
1980 17
1981 13
1982 17
1983 16
1984 17
1985 28
1986 26
1987 39
1988 34
1989 47
1990 38
1991 47
1992 39
1993 54
1994 71
1995 63
1996 87
1997 75
1998 84
1999 73
2000 68
2001 82
2002 82
2003 78
2004 92
2005 125
2006 151
2007 147
2008 162
2009 194
2010 191
2011 220
2012 230
2013 259
2014 267
2015 302
2016 299
2017 312
2018 348
2019 373
2020 410
2021 504
2022 513
2023 501
2024 479
2025 530
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,120 results

Results by year

Filters applied: . Clear all
Page 1
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2.
Khanani AM, Kotecha A, Chang A, Chen SJ, Chen Y, Guymer R, Heier JS, Holz FG, Iida T, Ives JA, Lim JI, Lin H, Michels S, Quezada Ruiz C, Schmidt-Erfurth U, Silverman D, Singh R, Swaminathan B, Willis JR, Tadayoni R; TENAYA and LUCERNE Investigators. Khanani AM, et al. Among authors: chang a. Ophthalmology. 2024 Aug;131(8):914-926. doi: 10.1016/j.ophtha.2024.02.014. Epub 2024 Feb 19. Ophthalmology. 2024. PMID: 38382813 Free article. Clinical Trial.
Neuro-immune cross-talk in cancer.
Amit M, Eichwald T, Roger A, Anderson J, Chang A, Vermeer PD, Dixon KO, Scheff NN, Talbot S. Amit M, et al. Among authors: chang a. Nat Rev Cancer. 2025 Aug;25(8):573-589. doi: 10.1038/s41568-025-00831-w. Epub 2025 Jun 16. Nat Rev Cancer. 2025. PMID: 40523971 Review.
Nociceptor neurons promote PDAC progression and cancer pain by interaction with cancer-associated fibroblasts and suppression of natural killer cells.
Wang K, Ni B, Xie Y, Li Z, Yuan L, Meng C, Zhao T, Gao S, Huang C, Wang H, Ma Y, Zhou T, Feng Y, Chang A, Yang C, Yu J, Yu W, Zang F, Zhang Y, Ji RR, Wang X, Hao J. Wang K, et al. Among authors: chang a. Cell Res. 2025 May;35(5):362-380. doi: 10.1038/s41422-025-01098-4. Epub 2025 Mar 24. Cell Res. 2025. PMID: 40122998
The structure of human sweetness.
Juen Z, Lu Z, Yu R, Chang AN, Wang B, Fitzpatrick AWP, Zuker CS. Juen Z, et al. Among authors: chang an. Cell. 2025 Jul 24;188(15):4141-4153.e18. doi: 10.1016/j.cell.2025.04.021. Epub 2025 May 7. Cell. 2025. PMID: 40339580 Free article.
Dynamic fibroblast-immune interactions shape recovery after brain injury.
Ewing-Crystal NA, Mroz NM, Larpthaveesarp A, Lizama CO, Pennington R, Chiaranunt P, Dennis JI, Chang AA, Merrill ED, Caryotakis SE, Kirthivasan N, Teo L, Tsukui T, Katewa A, McKinsey GL, Nelson SCK, Ciesielska A, Lummis NC, Pintarić L, Dahlgren MW, Atakilit A, Paidassi H, Jain S, Liu X, Xu D, Aghi MK, Bourne JA, Paz JT, Daneman R, Gonzalez FF, Sheppard D, Molofsky AV, Arnold TD, Molofsky AB. Ewing-Crystal NA, et al. Among authors: chang aa. Nature. 2025 Oct;646(8086):934-944. doi: 10.1038/s41586-025-09449-2. Epub 2025 Sep 3. Nature. 2025. PMID: 40903576 Free PMC article.
Voclosporin Nephrotoxicity: A Myth Debunked?
Chang A. Chang A. Arthritis Rheumatol. 2025 Oct;77(10):1289-1290. doi: 10.1002/art.43208. Epub 2025 Jun 10. Arthritis Rheumatol. 2025. PMID: 40317997 No abstract available.
7,120 results